ANAVEX LIFE SCIENCES CORP. Preferred Stock, Shares Authorized
ANAVEX LIFE SCIENCES CORP. (AVXL) had Preferred Stock, Shares Authorized of 10.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-28
- 2026-06-30: Preferred Stock, Shares Authorized 10.00M shares.
- 2026-03-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2025-12-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2025-09-30: Preferred Stock, Shares Authorized 10.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 10.00M shares 10-Q · filed 2026-08-28 |
| 2026-03-31 | 10.00M shares 10-Q · filed 2026-08-28 |
| 2025-12-31 | 10.00M shares 10-Q · filed 2026-02-09 |
| 2025-09-30 | 10.00M shares 10-K/A · filed 2026-08-28 |
| 2025-06-30 | 10.00M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 10.00M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 10.00M shares 10-Q · filed 2025-02-12 |
| 2024-09-30 | 10.00M shares 10-K/A · filed 2026-08-28 |
| 2024-06-30 | 10.00M shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 10.00M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 10.00M shares 10-Q · filed 2024-02-07 |
| 2023-09-30 | 10.00M shares 10-K · filed 2024-12-23 |
| 2023-06-30 | 10.00M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 10.00M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 10.00M shares 10-Q · filed 2023-02-07 |
| 2022-09-30 | 10.00M shares 10-K · filed 2023-11-27 |
| 2022-06-30 | 10.00M shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 10.00M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 10.00M shares 10-Q · filed 2022-02-09 |
| 2021-09-30 | 10.00M shares 10-K · filed 2022-11-28 |
| 2021-06-30 | 10.00M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 10.00M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 10.00M shares 10-Q · filed 2021-02-16 |
| 2020-09-30 | 10.00M shares 10-K · filed 2021-11-24 |
| 2020-06-30 | 10.00M shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 10.00M shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 10.00M shares 10-Q · filed 2020-02-06 |
| 2019-09-30 | 10.00M shares 10-K · filed 2020-12-28 |
| 2019-06-30 | 10.00M shares 10-Q · filed 2019-08-07 |
| 2018-09-30 | 10.00M shares 10-K · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |